Literature DB >> 2845154

Serum lactate dehydrogenase isoenzyme 1 as a marker of testicular germ cell tumor.

F E von Eyben1, O Blaabjerg, P H Petersen, M Hørder, H V Nielsen, S Kruse-Andersen, E Parlev.   

Abstract

Serum lactate dehydrogenase isoenzyme 1 activity was determined repeatedly in 21 men with testicular germ cell tumors in connection with orchiectomy and in 25 without neoplasia who underwent exploration of the testis. The highest level in the men without malignancy was 109 units per 1. and a higher pre-orchiectomy level was found in 15 of the tumor patients: 7 of 11 with seminoma and 8 of 10 with nonseminomatous tumors. In the patients with stage 3 disease serum lactate dehydrogenase isoenzyme 1 was increased more often and the activity was higher than in the stage 1 and 2 cancer patients. Within 1 month after orchiectomy the initially increased level decreased to less than 109 units per 1. in 8 of 10 patients with a stage 1 tumor and it remained higher in 5 with stage 2 or 3 disease. Serum lactate dehydrogenase isoenzyme 1 seems to be a useful marker of testicular germ cell tumor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845154     DOI: 10.1016/s0022-5347(17)41906-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

1.  An assessment of combined tumour markers in patients with seminoma: placental alkaline phosphatase (PLAP), lactate dehydrogenase (LD) and beta human chorionic gonadotrophin (beta HCG).

Authors:  A J Munro; O S Nielsen; W Duncan; J Sturgeon; M K Gospodarowicz; A Malkin; G M Thomas; M A Jewett
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

2.  Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.

Authors:  Klaus-Peter Dieckmann; Hanna Simonsen-Richter; Magdalena Kulejewski; Petra Anheuser; Henrik Zecha; Hendrik Isbarn; Uwe Pichlmeier
Journal:  Biomed Res Int       Date:  2019-05-28       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.